`
`
`Trials@uspto.gov
`571-272-7822 Date: January 27, 2022
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`v.
`NOVARTIS PHARMA AG, NOVARTIS TECHOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`____________
`
`IPR2021-00816
`Patent 9,220,631 B2
`____________
`
`
`
`Before ERICA A. FRANKLIN, ROBERT L. KINDER, and
`KRISTI L. R. SAWERT, Administrative Patent Judges.
`
`KINDER, Administrative Patent Judge.
`
`
`
`ORDER
`Granting Petitioner’s Motion for
`Pro Hac Vice Admission of Robert Vlasis
`37 C.F.R. § 42.10
`
`
`
`
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`
`
`On January 26, 2022, Petitioner filed a motion and supporting
`declaration for admission pro hac vice of Robert Vlasis. See Paper 44;
`Ex. 1098.
`Having reviewed the motion and declaration, we conclude that
`Mr. Vlasis has sufficient qualifications to represent Petitioner in these
`proceedings, and that Petitioner has shown good cause for admission pro
`hac vice of Mr. Vlasis. See Unified Patents, Inc. v. Parallel Iron, LLC,
`IPR2013-00639, Paper 7 (PTAB Oct. 15, 2013) (order authorizing Motion
`for Admission Pro Hac Vice) (setting forth the requirements for admission
`pro hac vice). Mr. Vlasis will be permitted to appear pro hac vice as back-
`up counsel only. See 37 C.F.R. § 42.10(c).
`A Power of Attorney has not been submitted for Mr. Vlasis.
`Accordingly, Petitioner must submit a Power of Attorney for Mr. Vlasis in
`accordance with 37 C.F.R. § 42.10(b), and must update its Mandatory
`Notices as required by 37 C.F.R. § 42.8(b)(3), to identify Mr. Vlasis as back-
`up counsel.
`In consideration of the foregoing, it is hereby:
`ORDERED that Petitioner’s motion for admission pro hac vice of
`Robert Vlasis in this proceeding is granted, and Mr. Vlasis is authorized to
`represent Petitioner only as back-up counsel;
`FURTHER ORDERED that Petitioner is to continue to have a
`registered practitioner as lead counsel in this proceeding;
`FURTHER ORDERED that Mr. Vlasis is to comply with the Patent
`Trial and Appeal Board’s Consolidated Trial Practice Guide (November
`2019), available at https://www.uspto.gov/TrialPracticeGuideConsolidated,
`
`2
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`
`and the Board’s Rules of Practice for Trials, as set forth in Part 42 of
`Title 37, Code of Federal Regulations;
`FURTHER ORDERED that Mr. Vlasis is subject to the USPTO’s
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a), and the USPTO’s Rules
`of Professional Conduct set forth at 37 C.F.R. §§ 11.101–11.901;
`FURTHER ORDERED that Petitioner shall submit, within ten (10)
`business days of the date of this order, a Power of Attorney for Mr. Vlasis in
`accordance with 37 C.F.R. § 42.10(b) in this proceeding; and
`FURTHER ORDERED that Petitioner shall file an updated mandatory
`notice in this proceeding, within ten (10) business days of the date of this
`order, according to 37 C.F.R. § 42.8(b)(3), providing updated information
`regarding back-up counsel.
`
`
`3
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`
`FOR PETITIONER:
`
`Elizabeth Weiswasser
`Anish Desai
`Christopher Pepe
`WEIL, GOTSHAL & MANGES LLP
`elizabeth.weiswasser@weil.com
`anish.desai@weil.com
`christopher.pepe@weil.com
`
`
`For PATENT OWNER:
`
`Elizabeth Holland
`William James
`Linnea Cipriano
`Joshua Weinger
`
`Nicholas Mitrokostas
`GOODWIN PROCTER LLP
`eholland@goodwinprocter.com
`wjames@goodwinlaw.com
`lcipriano@goodwinlaw.com
`jweinger@goodwinprocter.com
`nmitrokostas@goodwinlaw.com
`
`4
`
`